Online tools & resources

Training and Support

demo_pricing_button      login_button

FAQ

What is Embase?

Embase is a highly versatile, multipurpose and up-to-date database covering the most important international biomedical literature from 1947 to the present day. For further details see About Embase

What are the main benefits of Embase?

Embase provides extensive and reliable coverage of the peer-reviewed biomedical literature, along with in-depth indexing and powerful search and information management tools. With Embase, you can be confident that you have access to the most relevant and up-to-date information from the biomedical literature. For further details see who uses Embase.

What is Embase Classic?

Embase Classic is the Embase back file covering almost 2 million biomedical and pharmacological citations drawn from over 3,000 international titles from between 1947 and 1973. For further details please contact your regional office. 

If using MEDLINE, do I  need Embase?

Embase has significant content not available from PubMed, as well as in-depth indexing that makes even shared information uniquely retrievable from Embase.

Examples include:
  • Over 2000 journals not indexed on PubMed, especially from countries outside North America
  • Over 300,000 conference abstracts from 1000 conferences each year (since 2009)
  • In-depth drug and medical device indexing based on the Emtree Life Science thesaurus, which has over twice as many terms as the PubMed (MEDLINE) thesaurus (MeSH)


If I have Scopus, do I need Embase?

As an all-science database, Scopus includes most (but not all) the content of Embase, including most (but not all) Embase index terms.

However, since Scopus does not make use of the Embase thesaurus (Emtree) to facilitate synonym mapping and hierarchical searches, search results can be significantly less than on Embase. For example, a Scopus search on “heart attack” misses records mentioning “myocardial infarction” or indexed using the Emtree term “heart infarction”. In addition, Embase subheadings are not available on Scopus, so that it is not possible to limit drug searches (for example) to records focusing on adverse effects.

How do I stay up to date with Embase?

Information about the latest release is provided on the Latest release news page of the Embase Info site. Alternatively you can access All Embase release news for information about past releases, or subscribe to the Embase newsletter. You can also follow Embase via Twitter.

How current is Embase?

New records are added to Embase every working day, with on average over 3000 records a day (corresponding to over 800,000 records each year), of which about 75% are from Embase and 25% from unique MEDLINE. Articles in Press and In Process are added as soon as available. Since 2009, conferences abstracts are also added to Embase. Please see the coverage page for an up to date list of all conferences covered in Embase.

How is Embase indexed?

Fully indexed records in Embase (excluding unique MEDLINE) are manually indexed on the basis of the full text of the article. It is done by trained indexers with a biomedical background. Biomedical terms identified by indexers are controlled against Emtree before being added to records online. The entire process (including data input of Citation and Abstract) takes on average two weeks from receipt of the journal issue.For unique MEDLINE records, index terms assigned by the NLM (which are controlled via the MeSH thesaurus) are mapped to EMTREE terms - making use of the fact that all MeSH terms are included within EMTREE. Please refer to the Embase Indexing Guide for more information.

How do I find out about pricing?

Pricing is based on the number of biomedical users and is at this time only available for institutional access, this is not individual access. Please use the contact form on the info site if you would like help in finding out about the possibilities of Embase at your institution. If you would like to find out about institutional pricing, please contact your regional help desk.

Are usage statistics available?

Once we have your contact details, usage stats are sent automatically on the first day of the month. You will receive a report outlining the number of sessions, the number of searches and the types of searches (quick, advanced, EMTREE, author, journal) year to date, month by month. Please contact your regional helpdesk to set up a usage report.





Webinars

Upcoming
Archive


Please note: Embase webinars run on the FOURTH Wednesday of every month.

Embase: Searching for Evidence-based-medicine
Wednesday, May 22 2013, 16.00 – 16.45 CET (Amsterdam)
Register: https://www3.gotomeeting.com/register/623795966


Tech Specs

25 million indexed records, drawn from over 7,600 journals.
All of Medline included.
5 million records and 2,000 journals not covered by Medline also included.
Over 1,800 journal titles provide a data feed of not-yet-published Articles in Press.
More than 5,000 titles deliver not-yet-fully-indexed In Process records.
Access 2,500+ conferences and more than 800,000 conference abstracts.  Each year, over 300,000 new conference abstracts are indexed.
Locate almost 2 million biomedical and pharmacological citations, drawn from over 3,000 international titles.

Guides and Manuals

Below you’ll find a collection of whitepapers, customer stories and reports that we’d like to make available to you.
 

Coverage of MEDLINE on Embase
Coverage of MEDLINE on Embase		 Finding Medical Devices on Embase
Finding Medical Devices on Embase
 
How Embase supports the information needs of Pharmacovigilance Teams
How Embase supports the information needs of Pharmacovigilance Teams		 What are the differences between Emtree and MeSH?
What are the differences between Emtree and MeSH?
 
Embase Interview: Federico Aletti, Researcher, PhD Dipartimento di Bioingegneria, Politecnico di Milano
Embase Interview: Federico Aletti, Researcher, PhD Dipartimento di Bioingegneria, Politecnico di Milano		 EMBASE Whitepaper - Conducting Medical Device Safety and Performance Assessments
EMBASE Whitepaper - Conducting Medical Device Safety and Performance Assessments

Our Offices

USA, Canada and Latin America:

(8am-8pm CET - St.Louis)
Tel: US toll-free: +1 (888) 615 4500
Tel: Non toll-free: +1 (314) 523 4900
Email: usinfo@elsevier.com
Email Brazil: brinfo@elsevier.com

 Europe, Middle East and Africa:

(9am-6pm GMT+1, Amsterdam office)
Tel: +31 20 485 3767
Email: nlinfo@elsevier.com
Japan:

(9,30am-5,30pm JST, Tokyo office)
Tel: +81 (3) 5561 5035
Email: jpinfo@elsevier.com
Website: japan.elsevier.com		 Asia and Australasia:

(9am-6pm SST, Singapore office)
Tel: +65 6349 0222
Email: sginfo@elsevier.com